医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

International Olympic Committee and GE Healthcare Launch Analytics Tool to Help Drive Precision Health at the Olympic Winter Games

2018年02月06日 AM12:10
このエントリーをはてなブックマークに追加


 

PYEONGCHANG, South Korea

GE Healthcare today announced a new advanced analytics solution built for the Olympic Winter Games PyeongChang 2018 and to be used for the Olympic Games Tokyo 2020. Designed in partnership with the International Olympic Committee (IOC), the tool integrates valuable information, such as athlete injury and illness data, with venue, sport and training procedures, to help ensure clinicians have a comprehensive view of a patient’s health and can make an informed, rapid treatment decision. The insights also aim to inform long-term improvements to health and safety at the Olympic Games.

The GE Athlete Management Solution (AMS) collects multiple kinds of data, including imaging scans, patient vitals, and venue, event and sport-specific information, and provides real-time dashboards that can help inform medical staff and allow them to personalize treatment for athletes while identifying trends in injury and illness across the Games. For example, the tool can flag a “hot spot” where multiple injuries are occurring, or a spike in illness among spectators who attended an event at a specific venue . The tool is cloud-based, embedded with appropriate security controls, and enables remote entry of and access to data by clinicians anywhere and at any time – whether they are in a Polyclinic, the facility that provides care to anyone involved in the Games, a local hospital, or their hotel room.

“Through digital transformation, the IOC is pursuing its mission of helping to prevent injuries among our world-class athletes,” said Dr. Richard Budgett, Medical and Scientific Director for the IOC. “With 40 sports across the Olympic Games and Olympic Winter Games, each athlete requires unique healthcare monitoring and care. AMS will provide information that helps clinicians personalize training and treatment, so Olympians are best positioned to compete.”

The solution reflects GE Healthcare’s commitment to precision health, a holistic approach to patient care which encompasses diagnostics, therapeutics and monitoring to help ensure that appropriate actions are taken at the right time for each individual patient. In the context of the Games, this means considering differences in athlete’s medical histories, training environments and sport.

With the multilingual AMS, team doctors from different countries can work and collaborate with other physicians in their native language, all with the click of a button. Supported languages include English, French, Arabic, Russian, Chinese, Japanese, German, Spanish and Korean. All AMS terms and data were edited and validated by native speakers to help ensure proper and accurate translation. Additional information such as medications approved for prescription is also integrated into the solution. All features aim to inform the IOC and clinicians so that they have the ability to rapidly and effectively address injury and illness, with the goal of driving the best possible performance by athletes and the best possible experience for spectators.

“Olympians train for many years to represent their nations at the Games,” said Dr. Jorg Debatin, Vice President & Chief Technology Officer for GE Healthcare. “Their Herculean efforts must be matched with superhuman clinical speed and quality. AMS helps clinicians do just that – by making data and actionable insights readily available to the treating clinicians.”

Representatives from the United States Center for Disease Control, the Korean Center for Disease Control and Prevention, and the Public Health England Centre of Infectious Disease Surveillance and Control have all been trained on AMS and will use the solution to support public health monitoring during the Games.

About GE Healthcare

Harnessing data and analytics across hardware, software and biotech, GE Healthcare is the $19 billion healthcare business of GE (NYSE:GE). As a leading provider of medical imaging equipment, with a track record of more than 100 years in the industry and more than 50,000 employees across 100 countries, we transform healthcare by delivering better outcomes for providers and patients. Follow us on FacebookLinkedIn, and Twitter or The Pulse for latest news.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180205005561/en/

CONTACT

GE Healthcare
Kelley Sousa
(312) 288-1249
Kelley.Sousa@ge.com

同じカテゴリーの記事 

  • 大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表
  • Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
  • 领先的合同开发和制造组织PCI Pharma Services发布首份综合ESG报告
  • EverEx Secures iF Design Award for “MORA,” a Leading Musculoskeletal Rehabilitation Solution
  • Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer